|
Market Closed -
NYSE
23:30:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 10.62 USD | -3.28% |
|
-5.01% | -28.00% |
| 09-01 | Daxor Corporation Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 07-30 | Daxor Launches Blood Testing Lab in Eastern Kansis | MT |
Evolution of the Average Target: Daxor Corporation
Data source:
Daxor Corporation(DXR)
Evolution of the Target Price: Daxor Corporation
Data source:
Daxor Corporation(DXR)
Changes in Analyst Recommendations: Daxor Corporation
Data source:
Daxor Corporation(DXR)
5cea.g73MncFQItKkSaK-V0g7So9_xgJmWtTf-DVS32zGhME.1dCa5LJjGoP0DNbMEhhKe-Ens2UTCpmvlFkFniT266Xsx4fc8DVau-gRyQ~2a23a9c6b7092203d242f6da14591761


Analysts' Consensus
Sell
Buy

Mean consensus
BUY
Number of Analysts
2
Last Close Price
10.62USD
Average target price
20.00USD
Spread / Average Target
+88.32%
High Price Target
22.00USD
Spread / Highest target
+107.16%
Low Price Target
18.00USD
Spread / Lowest Target
+69.49%
Analyst Consensus Detail
Consensus revision (last 18 months)
- Stock Market
- Stocks
- DXR Stock
- DXR Stock
- Consensus Daxor Corporation
Select your edition
All financial news and data tailored to specific country editions
















